berberine has been researched along with Local Neoplasm Recurrence in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine was widely implemented in clinic treatment of breast cancer." | 5.51 | Berberine Inhibits Proliferative Ability of Breast Cancer Cells by Reducing Metadherin. ( Sun, Y; Tong, Y; Wang, W, 2019) |
| "Berberine was widely implemented in clinic treatment of breast cancer." | 1.51 | Berberine Inhibits Proliferative Ability of Breast Cancer Cells by Reducing Metadherin. ( Sun, Y; Tong, Y; Wang, W, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, CS | 1 |
| Tan, HY | 1 |
| Zhang, C | 1 |
| Chan, YT | 1 |
| Zhang, ZJ | 1 |
| Man, K | 1 |
| Yuen, MF | 1 |
| Wang, N | 1 |
| Feng, Y | 1 |
| Zhang, F | 1 |
| Jia, Y | 1 |
| Zheng, X | 1 |
| Shao, D | 1 |
| Zhao, Y | 1 |
| Wang, Z | 1 |
| Dawulieti, J | 1 |
| Liu, W | 1 |
| Sun, M | 1 |
| Sun, W | 1 |
| Pan, Y | 1 |
| Cui, L | 1 |
| Wang, Y | 1 |
| He, K | 1 |
| Zhang, M | 1 |
| Li, J | 1 |
| Dong, WF | 1 |
| Chen, L | 1 |
| Sun, Y | 1 |
| Wang, W | 1 |
| Tong, Y | 1 |
| Kim, SY | 1 |
| Hwangbo, H | 1 |
| Lee, H | 1 |
| Park, C | 1 |
| Kim, GY | 1 |
| Moon, SK | 1 |
| Yun, SJ | 1 |
| Kim, WJ | 1 |
| Cheong, J | 1 |
| Choi, YH | 1 |
| Kim, S | 1 |
| You, D | 1 |
| Jeong, Y | 1 |
| Yu, J | 1 |
| Kim, SW | 1 |
| Nam, SJ | 1 |
| Lee, JE | 1 |
| Li, X | 1 |
| Zhao, SJ | 1 |
| Shi, HL | 1 |
| Qiu, SP | 1 |
| Xie, JQ | 1 |
| Wu, H | 1 |
| Zhang, BB | 1 |
| Wang, ZT | 1 |
| Yuan, JY | 1 |
| Wu, XJ | 1 |
6 other studies available for berberine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Berberine suppresses metastasis and recurrence of hepatocellular carcinoma by targeting circulating tumour cells: abridged secondary publication.
Topics: Berberine; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Neoplasm Metastasis | 2022 |
Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Carcinoma, Hepatocellular; Doxorubicin; Drug C | 2019 |
Berberine Inhibits Proliferative Ability of Breast Cancer Cells by Reducing Metadherin.
Topics: Adult; Apoptosis; Berberine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2019 |
Induction of Apoptosis by Coptisine in Hep3B Hepatocellular Carcinoma Cells through Activation of the ROS-Mediated JNK Signaling Pathway.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Humans; JNK Mitogen-Ac | 2020 |
Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells.
Topics: Berberine; Cell Line, Tumor; Cell Proliferation; Down-Regulation; ErbB Receptors; Female; Humans; In | 2018 |
Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells.
Topics: Apoptosis; Berberine; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neopla | 2014 |